──New Patient Data Further Implicates CCL24 in Fibrotic Disease Pathology and Prognosis and Supports Rationale for the Role of Chemomab's CCL24-Neutralizing Antibody CM-101 in Systemic...

New program empowers developers at non-profit organizations to quickly build web and mobile applications without the high barriers of cost or managing search infrastructure. EL SEGUNDO, Calif.,...

Keynote address unveils the future of cooking with AR glasses World renowned Chef Ming Tsai demonstrates NEW YORK, June 2, 2023 /PRNewswire/ -- Kittch, the leading innovator in culinary...

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive...

Next-gen cybersecurity tool looks to revolutionize information security by leveraging the BSV blockchain LONDON, June 2, 2023 /PRNewswire/ -- Yesterday, at the London Blockchain Conference,...